Xylem (NYSE:XYL) Price Target Cut to $150.00 by Analysts at Mizuho

Xylem (NYSE:XYL) had its price objective lowered by Mizuho from $160.00 to $150.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has a “neutral” rating on the industrial products company’s stock. Mizuho’s target price would suggest a potential upside of 9.40% from the stock’s current price.

XYL has been the topic of a number of other research reports. Barclays increased their price objective on shares of Xylem from $165.00 to $172.00 and gave the stock an “overweight” rating in a report on Wednesday, October 29th. Citigroup increased their price target on shares of Xylem from $173.00 to $182.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. Weiss Ratings reissued a “buy (b-)” rating on shares of Xylem in a report on Monday, December 29th. TD Cowen upped their price objective on Xylem from $130.00 to $135.00 and gave the stock a “hold” rating in a report on Friday, December 5th. Finally, Royal Bank Of Canada increased their price objective on Xylem from $169.00 to $176.00 and gave the company an “outperform” rating in a research report on Wednesday, October 29th. Eight research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $166.40.

Xylem Stock Performance

NYSE:XYL opened at $137.12 on Monday. The stock has a market capitalization of $33.38 billion, a P/E ratio of 35.25, a price-to-earnings-growth ratio of 1.94 and a beta of 1.17. The company has a current ratio of 1.96, a quick ratio of 1.50 and a debt-to-equity ratio of 0.17. Xylem has a 1 year low of $100.47 and a 1 year high of $154.27. The firm has a 50 day moving average of $142.18 and a 200-day moving average of $140.32.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share for the quarter, beating analysts’ consensus estimates of $1.23 by $0.14. The firm had revenue of $2.27 billion during the quarter, compared to analysts’ expectations of $2.22 billion. Xylem had a return on equity of 10.77% and a net margin of 10.66%.The business’s revenue was up 7.8% on a year-over-year basis. During the same period last year, the firm posted $1.11 EPS. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. As a group, sell-side analysts anticipate that Xylem will post 4.65 EPS for the current fiscal year.

Insider Transactions at Xylem

In other news, Director Victoria D. Harker sold 1,700 shares of the business’s stock in a transaction dated Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total transaction of $251,838.00. Following the completion of the transaction, the director directly owned 16,875 shares in the company, valued at approximately $2,499,862.50. The trade was a 9.15% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Claudia S. Toussaint sold 10,421 shares of the stock in a transaction that occurred on Thursday, October 30th. The shares were sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the completion of the sale, the executive vice president owned 31,250 shares in the company, valued at $4,770,000. This represents a 25.01% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.27% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Xylem

Several institutional investors and hedge funds have recently made changes to their positions in the company. SJS Investment Consulting Inc. boosted its position in Xylem by 1,844.4% during the 3rd quarter. SJS Investment Consulting Inc. now owns 175 shares of the industrial products company’s stock worth $26,000 after acquiring an additional 166 shares during the last quarter. Knuff & Co LLC bought a new stake in shares of Xylem in the third quarter worth $27,000. Wexford Capital LP acquired a new position in Xylem during the third quarter worth $27,000. First Horizon Corp bought a new position in Xylem in the third quarter valued at $30,000. Finally, Ramirez Asset Management Inc. increased its stake in Xylem by 100.0% in the 3rd quarter. Ramirez Asset Management Inc. now owns 200 shares of the industrial products company’s stock valued at $30,000 after buying an additional 100 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.